drugset / Trial / NCT01837485

Probiotics in the Treatment of Irritable Bowel Syndrome

NCT01837485 ↗

Phase 2/3 Completed 82 enrolled Islamic Azad University, Najafabad Branch
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Some evidences have shown that probiotics are effective in the treatment of irritable bowel syndrome. Because few evidences are available in our population, we investigated if probiotics are effective in our patients as well. We hypothesize that the probiotic Lactol which contains Lactobacillus Sporogenes reduces the symptoms of irritable bowel syndrome.

Timeline

Start
2011-08
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactol Other / unclassified — —